SLT Holdings LLC acquired a new position in Exelon Corporation (NASDAQ:EXC - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,600 shares of the company's stock, valued at approximately $396,000.
Several other hedge funds and other institutional investors have also modified their holdings of EXC. Ameriflex Group Inc. acquired a new stake in Exelon in the 4th quarter worth $25,000. Hazlett Burt & Watson Inc. grew its position in Exelon by 46.4% during the first quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company's stock worth $32,000 after buying an additional 220 shares in the last quarter. ANTIPODES PARTNERS Ltd acquired a new stake in Exelon during the first quarter worth about $34,000. MJT & Associates Financial Advisory Group Inc. acquired a new stake in Exelon during the first quarter worth about $42,000. Finally, Redwood Park Advisors LLC acquired a new stake in shares of Exelon during the 4th quarter worth approximately $44,000. Institutional investors and hedge funds own 80.92% of the company's stock.
Exelon Price Performance
NASDAQ:EXC opened at $43.41 on Tuesday. The firm has a market cap of $43.82 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 2.58 and a beta of 0.39. Exelon Corporation has a 12 month low of $35.94 and a 12 month high of $48.11. The company has a quick ratio of 0.98, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. The company's 50-day moving average price is $43.23 and its two-hundred day moving average price is $43.45.
Exelon (NASDAQ:EXC - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.86 by $0.06. The business had revenue of $6.71 billion for the quarter, compared to the consensus estimate of $6.30 billion. Exelon had a return on equity of 10.29% and a net margin of 11.44%. Exelon's revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.68 EPS. On average, equities analysts anticipate that Exelon Corporation will post 2.64 EPS for the current fiscal year.
Analyst Ratings Changes
EXC has been the topic of several recent research reports. Evercore ISI lifted their price objective on Exelon from $48.00 to $51.00 and gave the stock an "in-line" rating in a report on Friday, May 2nd. Guggenheim lifted their price target on shares of Exelon from $47.00 to $50.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Wells Fargo & Company lifted their price target on shares of Exelon from $46.00 to $50.00 and gave the stock an "equal weight" rating in a research note on Friday, May 2nd. BMO Capital Markets lifted their target price on shares of Exelon from $46.00 to $50.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Finally, KeyCorp decreased their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 16th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Exelon has an average rating of "Hold" and a consensus price target of $47.20.
Check Out Our Latest Report on Exelon
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.